Cargando…

Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment

SIMPLE SUMMARY: Liver metastases occur in almost half of patients with colorectal cancer, either at the time of presentation (synchronous) or eventually as a metachronous recurrence of the disease. Approximately one quarter of patients with metastasis to the liver receive surgical resection with cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaharia, Claudia, Veen, Torhild, Lea, Dordi, Kanani, Arezo, Alexeeva, Marina, Søreide, Kjetil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818232/ https://www.ncbi.nlm.nih.gov/pubmed/36612177 http://dx.doi.org/10.3390/cancers15010181

Ejemplares similares

Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
por: Veen, Torhild, et al.
Publicado: (2023)

Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
por: Veen, Torhild, et al.
Publicado: (2017)

Management of severe liver injuries: push, pack, pringle – and plug!
por: Kanani, Arezo, et al.
Publicado: (2021)

Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
por: Søreide, Kjetil, et al.
Publicado: (2016)

Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
por: Søreide, Kjetil
Publicado: (2021)

Elevated microsatellite alterations at selected tetranucleotides in early‐stage colorectal cancers with and without high‐frequency microsatellite instability: same, same but different?
por: Watson, Martin M., et al.
Publicado: (2016)

Neoadjuvant immunotherapy in primary and metastatic colorectal cancer
por: Kanani, A, et al.
Publicado: (2021)

Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer
por: Watson, Martin M., et al.
Publicado: (2020)

Call for better response evaluation after neoadjuvant therapy in pancreatic cancer
por: Zaharia, Claudia, et al.
Publicado: (2023)

Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) Is Not Attributed to MSH3 Loss in Stage I-III Colon cancer: An Automated, Digitalized Assessment by Immunohistochemistry of Whole Slides and Hot Spots()()
por: Watson, Martin M, et al.
Publicado: (2019)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
por: Søreide, Kjetil, et al.
Publicado: (2014)

The prognostic relevance of examined lymph nodes for accurate staging of resected pancreatic adenocarcinoma
por: Zaharia, Claudia, et al.
Publicado: (2022)

Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
por: Roalsø, Marcus T. T., et al.
Publicado: (2022)

Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study
por: Höppener, Diederik J, et al.
Publicado: (2021)

A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment
por: Lea, Dordi, et al.
Publicado: (2021)

Structured and Systematic Team and Procedure Training in Severe Trauma: Going from ‘Zero to Hero’ for a Time-Critical, Low-Volume Emergency Procedure Over Three Time Periods
por: Meshkinfamfard, Maryam, et al.
Publicado: (2021)

International consensus guidelines for scoring the histopathological growth patterns of liver metastasis
por: van Dam, Pieter-Jan, et al.
Publicado: (2017)

Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery
por: Søreide, Kjetil, et al.
Publicado: (2023)

Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases
por: Stremitzer, Stefan, et al.
Publicado: (2020)

Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy
por: Höppener, D. J., et al.
Publicado: (2019)

Identification of Predominant Histopathological Growth Patterns of Colorectal Liver Metastasis by Multi-Habitat and Multi-Sequence Based Radiomics Analysis
por: Han, Yuqi, et al.
Publicado: (2020)

Long-Term Follow-Up and Survivorship After Completing Systematic Surveillance in Stage I–III Colorectal Cancer: Who Is Still at Risk?
por: Veen, T., et al.
Publicado: (2015)

Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases
por: Nierop, Pieter MH, et al.
Publicado: (2021)

Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases
por: Kong, Bing-Tan, et al.
Publicado: (2022)

The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study
por: Søreide, Jon Arne, et al.
Publicado: (2021)

Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
por: Berg, Marianne, et al.
Publicado: (2011)

Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases
por: Hu, Mingtao, et al.
Publicado: (2022)

Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases
por: Meyer, Y. M., et al.
Publicado: (2022)

Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials
por: Søreide, Kjetil
Publicado: (2016)

Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
por: Höppener, Diederik J., et al.
Publicado: (2020)

The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis
por: Chandra, Raghav, et al.
Publicado: (2021)

Evaluation of histopathological heterogeneity of colorectal cancer liver metastasis sites after preoperative chemotherapy
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2022)

Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected for Multiple Colorectal Liver Metastases
por: Eefsen, Rikke Løvendahl, et al.
Publicado: (2012)

Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases
por: Buisman, Florian E., et al.
Publicado: (2020)

The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases
por: Höppener, Diederik J., et al.
Publicado: (2022)

Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives
por: Zeng, Xuezhen, et al.
Publicado: (2021)

Clinical significance and changes to the immune microenvironment of colorectal cancer patients with liver metastasis
por: Wang, Ting, et al.
Publicado: (2023)

The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns
por: Garcia-Vicién, Gemma, et al.
Publicado: (2021)

Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver by Remodeling the Liver Immune Microenvironment
por: Yuan, Na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hst2lihvg32249h063keu9d1dg